Edwards Lifesciences cooperating with EU antitrust regulators 

Reuters exclusively reported that US medical device maker Edwards Lifesciences, a global leader in its field, was the target of an EU antitrust raid a week ago on concerns that it may have abuse its market power. Shares in Edwards Lifesciences shed 2.5% in pre-market trade on the Reuters story. The company, which can face fines up to 10% of its global turnover if found guilty of breaching EU antitrust rules and an order to change its business practices, subsequently confirmed that it had been raided. 

The post Edwards Lifesciences cooperating with EU antitrust regulators  appeared first on Reuters News Agency.